AngioScore Overview

  • Year Founded
  • 2003

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 149

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $230M

AngioScore General Information

Description

Developer of tools for endovascular therapy. The company develops angioplasty catheters for use in the treatment of cardiovascular and vascular disease.

Contact Information

Website
www.angioscore.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 5055 Brandin Court
  • Fremont, CA 94538
  • United States
+1 (510)
Primary Industry
Therapeutic Devices
Acquirer
The Spectranetics
Vertical(s)
Manufacturing
Corporate Office
  • 5055 Brandin Court
  • Fremont, CA 94538
  • United States
+1 (510)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

AngioScore Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Merger/Acquisition 30-Jun-2014 $230M Completed Generating Revenue
8. Secondary Transaction - Private 24-Jul-2012 Completed Generating Revenue
7. Secondary Transaction - Private Completed
6. Later Stage VC (Series F) 20-Apr-2011 Completed Generating Revenue
5. Later Stage VC (Series E) 09-Oct-2007 Completed Generating Revenue
4. Later Stage VC (Series D) 11-Apr-2006 Completed Generating Revenue
3. Later Stage VC (Series C) 19-Jul-2005 Completed Generating Revenue
2. Early Stage VC (Series B) 23-Aug-2004 $15.1M $16.8M Completed Generating Revenue
1. Early Stage VC (Series A) 28-Mar-2003 $1.63M $1.63M Completed Product Development
To view AngioScore’s complete valuation and funding history, request access »

AngioScore Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series F
Series E
Series D
Series C
Series B 6,751,590 $0.001000 8% $2.24 $2.24 1x $2.17 15.17%
Series A1 1,632,434 $0.001000 8% $1 $1 1x $1 3.55%
To view AngioScore’s complete cap table history, request access »

AngioScore Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of tools for endovascular therapy. The company develops angioplasty catheters for use in the treatment of card
Therapeutic Devices
Fremont, CA
149 As of 2014

Tirat Carmel, Israel
 

Santa Rosa, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

AngioScore Competitors (17)

One of AngioScore’s 17 competitors is Insightec, a Venture Capital-Backed company based in Tirat Carmel, Israel.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Insightec Venture Capital-Backed Tirat Carmel, Israel
Endologix Corporation Santa Rosa, CA
ShockWave Medical Formerly VC-backed Santa Clara, CA
Boston Scientific Corporation Marlborough, MA
Mercator MedSystems Venture Capital-Backed San Leandro, CA
You’re viewing 5 of 17 competitors. Get the full list »

AngioScore Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

AngioScore Former Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
California Technology Ventures Venture Capital Minority
Industry Ventures Venture Capital Minority
Innomed Ventures Venture Capital Minority
Jerusalem Global Ventures Venture Capital Minority
Linkagene Venture Capital Minority
You’re viewing 5 of 10 investors. Get the full list »

Ready to get started?

Request a free trial

AngioScore FAQs

  • When was AngioScore founded?

    AngioScore was founded in 2003.

  • Where is AngioScore headquartered?

    AngioScore is headquartered in Fremont, CA.

  • What is the size of AngioScore?

    AngioScore has 149 total employees.

  • What industry is AngioScore in?

    AngioScore’s primary industry is Therapeutic Devices.

  • Is AngioScore a private or public company?

    AngioScore is a Private company.

  • What is the current valuation of AngioScore?

    The current valuation of AngioScore is .

  • What is AngioScore’s current revenue?

    The current revenue for AngioScore is .

  • How much funding has AngioScore raised over time?

    AngioScore has raised $90.9M.

  • Who are AngioScore’s investors?

    California Technology Ventures, Industry Ventures, Innomed Ventures, Jerusalem Global Ventures, and Linkagene are 5 of 10 investors who have invested in AngioScore.

  • Who are AngioScore’s competitors?

    Insightec, Endologix, ShockWave Medical, Boston Scientific, and Mercator MedSystems are some of the 17 competitors of AngioScore.

  • When was AngioScore acquired?

    AngioScore was acquired on 30-Jun-2014.

  • Who acquired AngioScore?

    AngioScore was acquired by The Spectranetics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process